FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$9.50
-0.01 (-0.11%)
▼
5d:
-0.52%
30d:
-8.48%
90d:
-44.93%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 11, 2026
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FTRE trading at deep discount. Market pricing in -15.7% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: FTRE trading at deep discount. Market pricing in -15.7% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.97
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.23
50.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $9.50, which is considered fair relative to its 30-day fair value range of $9.19 to $10.33. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.9) compared to its historical average (16.5). Remarkably, the market is currently pricing in an annual earnings decline of 15.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $8.64, while resistance sits at $10.09.
Market Sentiment: FTRE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.35 (+50.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $8.64, while resistance sits at $10.09.
Market Sentiment: FTRE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.35 (+50.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$9.19 -
$10.33
Company Quality Score
52/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.8% below Wall St target ($14.35)
Fair Price Analysis
30-Day Fair Range
$9.19 -
$10.33
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.88
(9.3%)
Support & Resistance Levels
Support Level
$8.64
Resistance Level
$10.09
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.87
Wall Street Target
$14.35
(+50.8%)
Revenue Growth (YoY)
-5.2%
Earnings Growth (YoY)
-57.4%
Profit Margin
-36.2%
Valuation Discount vs History
-15.7% cheaper
PE vs Historical
9.9 vs 16.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.7%
(market-implied from PE analysis)
1-Year Target
$8.56
(-10%)
2-Year Target
$7.70
(-19%)
3-Year Target
$6.93
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→17)
$11.59
(+22%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 33.3%)
$51.05
(+437%)
Base:
(SPY PE: 9.9, Growth: 33.3%)
$22.54
(+137%)
Bear:
(PE: 8.4, Growth: 33.3%)
$19.16
(+101%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.9 to 16.5
Stabilization Target:
$15.90
(+67.2%)
PE Expansion Potential:
+67.2%
Share & Embed Analysis
Last updated: April 02, 2026 2:27 PM ET
Data refreshes hourly during market hours. Next update: 3:27 PM
Data refreshes hourly during market hours. Next update: 3:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell
SELL
1804 shares
2026-03-16
Jill G Mcconnell
SELL
5061 shares
2026-03-10
Robert Parks
SELL
1927 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
